Wan Bond (002082.SZ) announced that according to the pharmaceutical and health industry development strategy, in order to make full use of professional investment...
Zhitong Finance App News, according to Wan Bond (002082.SZ) announced that according to the pharmaceutical and health industry development strategy, in order to make full use of the professional resources and investment management advantages of professional investment institutions to lay out the company's investment in the medical and health industry and promote the company's long-term development, the company's wholly-owned subsidiary Wanbond (Hangzhou) Investment Management Co., Ltd. (“Wanbond Investment”) plans to participate in the Nanjing Aohan Investment Management Co., Ltd. (“Shanghai Aohan”) investment partnership (limited partnership) (abbreviation: “Shanghai Aohan”) “Investment funds ”). The investment direction of the investment fund is pharmaceutical, medical, health care, and new material companies. The investment fund's fundraising target is 1 billion yuan. The company plans to use its own capital of no more than 300 million yuan to subscribe for Aohan Ruikang's fund share as a limited partner.
